Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Cumulative Effect, Period of Adoption, Adjustment	Total
Beginning balance at Dec. 31, 2021	$ 137	$ 91,107		$ 117,626	$ (400)		$ 208,470
Beginning balance (in shares) at Dec. 31, 2021	13,669,772
Net Income				7,674			7,674
Other comprehensive income (loss)					(10,529)		(10,529)
Dividend declared on common stock ($0.20 per share)				(2,790)			(2,790)
Exercise of stock options	$ 2	1,889					1,891
Exercise of stock options (in shares)	206,472
Restricted stock vesting (in shares)	13,960
Share-based compensation		139					139
Ending balance at Mar. 31, 2022	$ 139	93,135		122,510	(10,929)		204,855
Ending balance (in shares) at Mar. 31, 2022	13,890,204
Beginning balance at Dec. 31, 2022	$ 141	94,726	$ (2,292)	146,630	(28,697)	$ (2,292)	212,800
Beginning balance (in shares) at Dec. 31, 2022	14,043,801
Net Income				6,304			6,304
Other comprehensive income (loss)					3,502		3,502
Exercise of stock options		312					312
Exercise of stock options (in shares)	26,625
Restricted stock vesting (in shares)	6,381
Share-based compensation		197					197
Ending balance at Mar. 31, 2023	$ 141	$ 95,235		$ 150,642	$ (25,195)		$ 220,823
Ending balance (in shares) at Mar. 31, 2023	14,076,807